FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1115-1117 April 15, 1993 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Although current epidemiologic evidence overwhelmingly supports the notion that estrogen-replacement therapy protects postmenopausal women against coronary artery disease, the appropriate treatment of these women with gonadal steroids remains controversial. To some extent, this controversy reflects physicians' reluctance to commit patients to decades of treatment with medications whose benefits have only been inferred from observational studies rather than demonstrated in prospective clinical trials. Also, most of the studies have included few details about the type or dose of estrogen or the duration of its use. The paucity of information on the combined use of estrogen and progestin is even more pronounced, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Tkac, I., Molcanyiova, A., Tkac, I. (1997). Fibrinogen and Albuminuria are Related to the Presence and Severity of Peripheral Arterial Disease in Women with Type 2 Diabetes Mellitus. ANGIOLOGY 48: 715-719 [Abstract]  
• Zumoff, B., Crook, D., Stevenson, J. C., Daubresse, J.-C., Bluming, A. Z., Nabulsi, A. A., Folsom, A. R., White, A., Martin, K. A., Freeman, M. W. (1993). Hormone Replacement and Cardiovascular Risk Factors. NEJM 329: 1041-1043 [Full Text]  
• (1993). PROGESTINS HAVE BENEFICIAL LIPID EFFECTS IN HORMONE THERAPY. JWatch General 1993: 1-1 [Full Text]